Welcome to our dedicated page for KIMBERLY CLARK SEC filings (Ticker: KMB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Kimberly-Clark Corporation’s SEC filings document its consumer products business, Nasdaq-listed common stock and formal reporting as an operating company. Material-event reports furnish quarterly and annual results, financial condition updates and exhibits, including Inline XBRL cover-page data and earnings releases.
Other filings cover proxy and governance disclosures, shareholder voting matters, executive officer departures and interim accounting-officer responsibilities, compensation arrangements, material agreements, registration-statement and proxy/prospectus materials, and capital-structure information. The record also identifies the company’s common stock with $1.25 par value and the exchange registration for KMB on Nasdaq.
Kimberly-Clark Corp: The Vanguard Group filed an Amendment No. 13 to Schedule 13G/A reporting that, following an internal realignment, it beneficially owns 0 shares of common stock of Kimberly-Clark and reports 0% of the class.
The filing states certain Vanguard subsidiaries or business divisions will report beneficial ownership separately following SEC Release No. 34-39538, and that The Vanguard Group, Inc. no longer is deemed to have beneficial ownership over securities held by those subsidiaries.
Kimberly-Clark Corporation is asking stockholders to vote at its virtual 2026 annual meeting on four key items: electing 13 directors, ratifying Deloitte & Touche as auditor, approving executive pay on an advisory basis, and a stockholder proposal for an independent board chair that the Board opposes.
The proxy highlights a transformational period, including a pending acquisition of Kenvue and a planned joint venture with Suzano for the International Family Care and Professional business, where Kimberly-Clark will retain a 49% interest. In 2025, net sales were $16.4 billion, down 2.1%, with organic sales up 1.7%, operating profit of $2.4 billion, adjusted operating profit of $2.7 billion, and adjusted EPS of $7.53. The company raised its dividend for the 54th consecutive year.
The Board is majority independent with a diverse mix of gender, tenure, and skills, and maintains an independent lead director structure. Executive pay is heavily performance-based; 2025 annual incentives paid below target after management fell short of financial and non-financial goals, while longer-term performance share units paid out at 150% of target. The proxy also details extensive sustainability goals toward 2030, including cutting greenhouse gas emissions and plastics usage, and reports meaningful progress on water, energy, and social impact initiatives.
KIMBERLY CLARK CORP executive Francesco Tinto filed an initial ownership report showing a small indirect stake in the company. The filing lists beneficial ownership of 45 shares of common stock, held indirectly through his spouse in a trust. It does not report any new open-market purchases or sales, but instead documents existing indirect holdings as part of his role as Chief Information & GBS Officer.
Kimberly-Clark describes a year of major strategic change, highlighted by a pending acquisition of Kenvue, Inc., a global consumer health company. Each Kenvue share is expected to be exchanged for 0.14625 Kimberly-Clark shares plus $3.50 in cash, with approximately 280 million new shares to be issued and about $6.7 billion of cash consideration funded by cash, new debt and proceeds from a separate transaction.
The company also plans an International Family Care and Professional joint venture with Suzano, under which Suzano will buy 51% of the business for about $1.7 billion, and Kimberly-Clark will retain 49%. That business is now reported as discontinued operations, and ongoing activities are organized into North America and International Personal Care segments.
Management launched a 2024 Transformation Initiative to create a more agile operating model, sharpen growth focus and improve margins through innovation, supply chain optimization and organizational changes. The filing details extensive risk factors, including raw material and energy volatility, cybersecurity threats, foreign exchange and geopolitical exposures, climate and sustainability pressures, higher post‑merger leverage and the possibility the Kenvue deal may be delayed or not close.
Kimberly-Clark director S. Todd Maclin reported an indirect purchase of company stock through a trust. On February 9, 2026, a trust associated with Maclin acquired 10,000 shares of Kimberly-Clark common stock at a weighted average price of $104.1467 per share.
After this transaction, the trust holds 10,000 shares, and Maclin also reports 2,400 shares held directly in his own name. The transaction was executed in multiple trades within a narrow price range around the reported average.
Kimberly-Clark director S. Todd Maclin reported acquiring additional company stock. On 03/31/2025, he acquired 134 shares of common stock at a price of $0.0000 per share, bringing his holdings to 2,134 shares. On 04/09/2025, he purchased a further 266 shares at $145.77 per share, increasing his directly held stake to 2,400 common shares.
Kimberly-Clark Corporation officer Andrew Scribner, who serves as Controller and Vice President of FP&A, reported a sale of company stock. On February 5, 2026, he sold 3,049 shares of Kimberly-Clark common stock at $104.29 per share. After this transaction, the filing shows he directly owned 0 shares of Kimberly-Clark common stock.
A holder of KMB common stock filed a Form 144 notice to sell 3,049 shares through Merrill Lynch on or about February 5, 2026 on Nasdaq. The shares were acquired via employment-related restricted stock award vests between January 2024 and May 2025, with compensatory payment dated February 6, 2026.
Kimberly-Clark Corporation’s General Counsel and Secretary, Grant B. McGee, reported the vesting of restricted share units and related share transactions. On January 31, 2026, 3,529 restricted share units granted on May 1, 2024 converted into the same number of shares of common stock at an exercise price of $0.0000 per share. In connection with this vesting, 1,451 shares of common stock were automatically surrendered to the issuer at $99.99 per share to satisfy tax withholding obligations. After these transactions, McGee directly held 4,748 shares of Kimberly-Clark common stock.